FINNENCE ▪ THE WIRE FILE
THE WIRE · № 78403
News■ Unclear/unknown
Samaritan-MultiCare merger wins final approval
KINDNews
DIRECTION■ Unclear/unknown
SOURCES3
ENTITIES1
STORY SIZE5 RECORDS
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Regional hospital merger approval; limited broader market transmission.
Local healthcare consolidation, narrow relevance
CATALYST TO WATCH
Integration and post-merger financials
MAIN RISK
Non-public entities, minimal tradable impact
02 THE STORY SO FAR
THE RECORD, IN ORDER.
UPDATED 5 TIMES · FIRST · LAST2026-10-13 17:38 UTCNewsMerger aims for expanded safety net access to VBC data and tools
2026-10-13 19:01 UTCNewsSamaritan-MultiCare merger wins final approvalCURRENT RECORD
2026-10-13 19:36 UTCNewsAlaunos lands Paragon-built pulmonary hypertension pipeline via Velaris merger
2026-10-13 21:00 UTCNewsIs Emera Stock a Buy Before Its Proposed Merger With Canadian Utilities?
2026-10-13 21:15 UTCNewsMSUFCU announces $13.5B merger with Texas-based credit union
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Kimberly-Clark’s $40 Billion Kenvue Takeover Clears EU Antitrust Review2026-10-13 19:02 UTC
Kimberly-Clark’s $40 Billion Kenvue Takeover Clears EU Antitrust Review2026-10-13 19:02 UTC
→CORRELATIONshares Healthcare
Social Security benefits are rising again, but probably not enough to offset healthcare costs2026-10-13 19:26 UTC
Social Security benefits are rising again, but probably not enough to offset healthcare costs2026-10-13 19:26 UTC
→CORRELATIONshares Healthcare
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)2026-10-13 19:36 UTC
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)2026-10-13 19:36 UTC
→CORRELATIONshares Healthcare
Alaunos lands Paragon-built pulmonary hypertension pipeline via Velaris merger2026-10-13 19:36 UTC
Alaunos lands Paragon-built pulmonary hypertension pipeline via Velaris merger2026-10-13 19:36 UTC
→CORRELATIONshares Healthcare
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 20262026-10-13 20:05 UTC
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 20262026-10-13 20:05 UTC
→CORRELATIONshares Healthcare
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter2026-10-13 20:30 UTC
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter2026-10-13 20:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.